---
title: "Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295018436.md"
description: "Corbus Pharmaceuticals Holdings Inc. (CRBP) shares rose 1.81% to $9.57, outperforming peers like Vanda Pharmaceuticals on a mixed trading day. This marks the second consecutive gain for CRBP, though it remains significantly below its 52-week high of $20.56. Trading volume was notably lower than the 50-day average."
datetime: "2026-08-05T21:22:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295018436.md)
  - [en](https://longbridge.com/en/news/295018436.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295018436.md)
generator: "portal-rs"
---

# Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) rallied 1.81% to $9.57 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.49% to 54,349.12 and the NASDAQ Composite Index falling 0.83% to 26,363.44.

This was the stock's second consecutive day of gains.

Corbus Pharmaceuticals Holdings Inc. closed 53.45% short of its 52-week high of $20.56, which the company achieved on October 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. (VNDA) fell 4.50% to $5.09, Fortress Biotech Inc. (FBIO) rose 2.57% to $2.79, and Viking Therapeutics Inc. (VKTX) rose 1.73% to $33.51.

Trading volume (234,209) remained 291,144 below its 50-day average volume of 525,353.

Data source: Dow Jones Market Data, FactSet. Data compiled August 5, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-05-26 1722ET

### Related Stocks

- [CRBP.US](https://longbridge.com/en/quote/CRBP.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)
- [FBIO.US](https://longbridge.com/en/quote/FBIO.US.md)
- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)
- [FBIOP.US](https://longbridge.com/en/quote/FBIOP.US.md)

## Related News & Research

- [Corbus Pharma CFO Sean Moran sells 12,000 shares for $120,971](https://longbridge.com/en/news/295447150.md)
- [Corbus Pharma CMO Nicacio Leonardo Viana files initial beneficial ownership statement](https://longbridge.com/en/news/294867785.md)
- [MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check](https://longbridge.com/en/news/297343211.md)
- [Merck & Co Inc Stock (MRK) Moved Up by 3.76% on Aug 25: A Full Analysis](https://longbridge.com/en/news/296946347.md)
- [Corbus says Phase 1b CANYON-1 obesity trial of CRB-913 reaches last patient last visit](https://longbridge.com/en/news/294824963.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**